Defence Therapeutics (XCNQ:DTC) LT-Debt-to-Total-Asset : 0.03 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Defence Therapeutics's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.03.

Defence Therapeutics's long-term debt to total assets ratio increased from Sep. 2022 (0.00) to Dec. 2023 (0.03). It may suggest that Defence Therapeutics is progressively becoming more dependent on debt to grow their business.

Defence Therapeutics LT-Debt-to-Total-Asset Historical Data

The historical data trend for Defence Therapeutics's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics LT-Debt-to-Total-Asset Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

LT-Debt-to-Total-Asset

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial										-	3.85	0.52	1.03	0.03

Defence Therapeutics LT-Debt-to-Total-Asset Calculation

Defence Therapeutics's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jun. 2022 is calculated as

LT Debt to Total Assets (A: Jun. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Jun. 2022 )	/	Total Assets (A: Jun. 2022 )
	=	0	/	0.72
	=

Defence Therapeutics's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0.023	/	0.669
	=

Defence Therapeutics (XCNQ:DTC) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Defence Therapeutics LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director